Unraveling the Impact of Lead-related Venous Obstruction in Patients with Cardiac Implantable Electronic Devices
Lead-related venous obstruction (LRVO) affects approximately 5% of patients with cardiac implantable electronic devices (CIEDs). This condition, associated with symptomatic complications, can be effectively managed through lead extraction, which has shown significant reductions in healthcare utilization.